Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Current Assets (2020 - 2025)

Historic Current Assets for Beauty Health (SKIN) over the last 6 years, with Q3 2025 value amounting to $308.4 million.

  • Beauty Health's Current Assets fell 3642.53% to $308.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $308.4 million, marking a year-over-year decrease of 3642.53%. This contributed to the annual value of $477.1 million for FY2024, which is 3166.88% down from last year.
  • Per Beauty Health's latest filing, its Current Assets stood at $308.4 million for Q3 2025, which was down 3642.53% from $306.1 million recorded in Q2 2025.
  • In the past 5 years, Beauty Health's Current Assets ranged from a high of $1.0 billion in Q4 2021 and a low of $3.3 million during Q1 2021
  • Its 5-year average for Current Assets is $617.6 million, with a median of $698.3 million in 2023.
  • As far as peak fluctuations go, Beauty Health's Current Assets soared by 2923620.17% in 2022, and later plummeted by 3748.15% in 2025.
  • Beauty Health's Current Assets (Quarter) stood at $1.0 billion in 2021, then dropped by 21.74% to $783.3 million in 2022, then dropped by 10.85% to $698.3 million in 2023, then crashed by 31.67% to $477.1 million in 2024, then crashed by 35.37% to $308.4 million in 2025.
  • Its last three reported values are $308.4 million in Q3 2025, $306.1 million for Q2 2025, and $469.4 million during Q1 2025.